BPC 157 does inhibit MAO-inhibition, modulates serotonergic and dopaminergic systems, beneficially affects various behavioral disturbances that otherwise appeared due to specifically (over)stimulated/damaged neurotransmitters systems
There are no registered human clinical trials, no approved human indication, and no human efficacy or safety data
How It Is Studied BPC-157 research in tendon and muscle models typically involves surgical transection or crush injury in rodents, followed by localized or systemic administration of the peptide
Once in solution, store at 4C and use within 28 days
5-Amino-1MQ is a small, non-hormonal molecule that targets lipid metabolism via NNMT inhibition and NAD+ preservation, without affecting appetite
two injections of BPC-157